Biotech RadarJobs updated

COMPANY

Dexcom

HQ: San Diego, CA source · dexcom.com ↗ · West Coast

FDA-cleared device company Clinical Phase 3

305 open jobs · last seen Oct 23, 2026 · 43 sources

Keywords: metabolic Diabetes Diabetes Mellitus Type 2 Diabetes Mellitus Type 1 Diabetes Mellitus Type 2 Diabetes Pre-diabetes Type 2 Diabetes on Insulin Dysglycemia Glucose Intolerance Hyperglycemia Dexcom CGM System Dexcom Continuous Glucose Monitoring System Continuous Glucose Monitoring System Continuous Glucose Monitoring Dexcom CGM G6/G6 Pro/G7 Dexcom CGM (Continuous Glucose Monitor) Real-Time Continuous Glucose Monitoring Dexcom G6 Continuous Glucose Monitor (CGM) System Acetaminophen Challenge (G6 CGM) Continuous Glucose Monitor DexCom™ G4 Continuous Glucose Monitoring System Continuous Glucose Monitoring of glucose levels (Dexcom) Dexcom G4 CGM System

Profile checked Oct 10, 2026

305+1 patient-care hiddenOpen jobs35Trials (company is sponsor)8FDA records (2 yrs)

Hiring

TitleLocation (from posting)Employer postedFirst seen
QC Inspector 3 - Morning ShiftAthenry, IrelandOct 23, 2026Oct 14, 2026
Sr Staff Forecast AnalystManila, PhilippinesOct 23, 2026Oct 23, 2026
Customer Advocacy GeneralistVilnius, LithuaniaOct 23, 2026Oct 23, 2026
Sr Enterprise Privacy Analyst, Maternity CoverVilnius, LithuaniaOct 22, 2026Oct 12, 2026
Sr Quality Assurance Analyst2 locations (listed on the posting)Oct 22, 2026Oct 20, 2026

See all 305 jobs

Timeline

  1. FDA FDA 510(k) clearance: Stelo Glucose Biosensor System — K262472, Aug 11, 2026. Applicant at approval: Dexcom, Inc. source ↗
  2. Trial start —: Global Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose Monitoring System (Dexcom GLOW) source ↗
  3. FDA FDA 510(k) clearance: Stelo Glucose Biosensor System — K260935, Jun 12, 2026. Applicant at approval: Dexcom, Inc. source ↗
  4. FDA FDA 510(k) clearance: Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System — K261402, Jun 8, 2026. Applicant at approval: Dexcom, Inc. source ↗
  5. FDA FDA 510(k) clearance: Stelo Glucose Biosensor System — K261359, May 21, 2026. Applicant at approval: Dexcom, Inc. source ↗
  6. FDA FDA 510(k) clearance: Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System — K253737, Feb 3, 2026. Applicant at approval: Dexcom, Inc. source ↗
  7. FDA FDA 510(k) clearance: Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System — K253710, Dec 17, 2025. Applicant at approval: Dexcom, Inc. source ↗
  8. Trial start Phase 4: Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi Arabia source ↗
  9. FDA FDA 510(k) clearance: Dexcom Smart Basal — K252818, Nov 18, 2025. Applicant at approval: Dexcom, Inc. source ↗
  10. FDA FDA 510(k) clearance: Dexcom G7 15 Day Continuous Glucose Monitoring System — K243214, Apr 9, 2025. Applicant at approval: Dexcom, Inc. source ↗
  11. Trial start Not phased (device or behavioral study): CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin source ↗
  12. Trial start —: Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry) source ↗
  13. Trial start Phase 1: Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor source ↗
  14. Trial start Not phased (device or behavioral study): Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dysglycemia source ↗
  15. Trial start —: Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus source ↗
  16. Trial start Not phased (device or behavioral study): Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient Setting source ↗
  17. Trial start Not phased (device or behavioral study): Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System source ↗
  18. Trial start —: Evaluation of Modified Adhesives With Dexcom G6 Sensor source ↗
  19. Trial start Not phased (device or behavioral study): Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System source ↗
  20. Trial start Not phased (device or behavioral study): Assessing Non-adjunctive CGM Safety at Home and in New Markets source ↗
  21. Trial start —: Prediabetes and Type 2 Diabetes Data Collection Study source ↗
  22. Trial start —: Performance of the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus source ↗
  23. Trial start —: Glucose Risk Assessment in Employer Populations source ↗
  24. Trial start Not phased (device or behavioral study): Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) source ↗
  25. Trial start Not phased (device or behavioral study): Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE) source ↗

Showing 25 of 43 dated events.

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 35

RecordTitlePhaseStatusStartPrimary completion
NCT06483945Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)Not listedActive, not recruitingFeb 28, 2024Mar 31, 2028 (estimated)
NCT06601166CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on InsulinNot phased (device or behavioral study)Active, not recruitingAug 15, 2024May 13, 2026 (actual)
NCT07681024Global Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose Monitoring System (Dexcom GLOW)Not listedNot yet recruitingJun 15, 2026May 1, 2030 (estimated)
NCT07681375Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 SensorPhase 1Active, not recruitingApr 11, 2023Jan 16, 2026 (actual)
NCT07603284Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi ArabiaPhase 4Active, not recruitingNov 24, 2025Nov 2, 2026 (estimated)
NCT05746286Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for DysglycemiaNot phased (device or behavioral study)CompletedFeb 1, 2023Nov 29, 2023 (actual)
NCT04529824Glucose Risk Assessment in Employer PopulationsNot listedCompletedApr 1, 2019Jul 22, 2019 (actual)
NCT04585139Assessing Non-adjunctive CGM Safety at Home and in New MarketsNot phased (device or behavioral study)CompletedOct 6, 2020Feb 7, 2022 (actual)
NCT04905628Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes MellitusNot listedUnknown status (ClinicalTrials.gov)Jul 8, 2021Mar 31, 2022 (estimated)
NCT04794478Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) SystemNot phased (device or behavioral study)CompletedFeb 19, 2021Aug 9, 2021 (actual)
NCT04503239Prediabetes and Type 2 Diabetes Data Collection StudyNot listedUnknown status (ClinicalTrials.gov)Jul 22, 2020Feb 27, 2022 (estimated)
NCT03340831Continuous Monitoring and Control of HypoglycemiaNot listedUnknown status (ClinicalTrials.gov)Oct 20, 2017Dec 30, 2023 (estimated)
NCT04879693Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient SettingNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)2021-062021-12 (estimated)
NCT03566693Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)Not phased (device or behavioral study)CompletedJul 30, 2018Jan 4, 2021 (actual)
NCT04840446Evaluation of Modified Adhesives With Dexcom G6 SensorNot listedCompletedFeb 8, 2021Mar 16, 2021 (actual)
NCT03620357Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)Not phased (device or behavioral study)CompletedSep 5, 2018May 27, 2020 (actual)
NCT04645641Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) SystemNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Oct 12, 20202020-12 (estimated)
NCT03935191Performance of the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes MellitusNot listedUnknown status (ClinicalTrials.gov)May 1, 2019May 31, 2019 (estimated)
NCT02880267Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring SystemNot phased (device or behavioral study)Completed2016-052017-07 (actual)
NCT03087877Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent SensorNot phased (device or behavioral study)CompletedFeb 3, 2017Mar 4, 2017 (actual)
NCT02087995Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified AlgorithmNot phased (device or behavioral study)Completed2013-122014-03 (actual)
NCT02363907Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 Continuous Glucose Monitoring System in PediatricsNot listedCompleted2012-092012-10 (actual)
NCT02282397Multiple Daily Injections and Continuous Glucose Monitoring in DiabetesNot phased (device or behavioral study)Completed2014-092016-11 (actual)
NCT01111370Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring SystemNot phased (device or behavioral study)Completed2010-022010-04 (actual)
NCT02696252G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor ApplicatorNot listedCompleted2016-012016-04 (actual)
NCT01514292Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring SystemNot phased (device or behavioral study)Completed2011-122012-02 (actual)
NCT01627184Long-term Use: CGM System Assessment in Adult Athletes With Diabetes MellitusNot listedCompleted2012-052013-01 (actual)
NCT01627210Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 SystemNot listedCompleted2012-052012-12 (actual)
NCT01667185Effectiveness and Safety of the Dexcom™ G4 Continuous Glucose Monitoring System in Pediatric Subjects With Diabetes MellitusNot listedCompleted2012-072012-12 (actual)
NCT01514305Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring SystemNot listedCompleted2011-112011-12 (actual)
NCT01185496Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes MellitusNot listedCompleted2010-082010-10 (actual)
NCT01104142Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) TherapyNot listedCompleted2009-04Not listed
NCT00925080Pivotal Study of the Intravenous Blood Glucose (IVBG) System, In-Clinic SettingNot listedCompleted2009-062009-07 (actual)
NCT00939289Concurrent Use of Two Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes Mellitus (T1DM)Not listedCompleted2008-072008-08 (actual)
NCT00722241Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring SystemNot listedCompleted2008-052008-06 (actual)

FDA records (last 2 years)

Open jobs 305

1 patient-care job hidden (phlebotomy, plasma-center, nursing and similar care roles; 306 open jobs in total).

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
QC Inspector 3 - Morning ShiftAthenry, IrelandOct 23, 2026Oct 14, 2026Not stated
Sr Staff Forecast AnalystManila, PhilippinesOct 23, 2026Oct 23, 2026Not stated
Customer Advocacy GeneralistVilnius, LithuaniaOct 23, 2026Oct 23, 2026Not stated
Sr Enterprise Privacy Analyst, Maternity CoverVilnius, LithuaniaOct 22, 2026Oct 12, 2026Senior
Sr Quality Assurance Analyst2 locations (listed on the posting)Oct 22, 2026Oct 20, 2026Not stated
Oracle Fusion Financials Analyst – Edinburgh, UKRemote - United KingdomOct 22, 2026Oct 22, 2026Not stated
Senior Tax AccountantManila, PhilippinesOct 22, 2026Oct 22, 2026Not stated
Territory Business Manager, Southlake TexasBedford, TexasOct 22, 2026Oct 23, 2026Not stated
Hardware Engineer 2San Diego, CaliforniaOct 22, 2026Oct 23, 2026Not stated
Manufacturing Technician 2-Monday-Friday (6:00AM-2:30PM)San Diego, CaliforniaOct 22, 2026Oct 23, 2026Not stated
Capability Leader - Fraud Management2 locations (listed on the posting)Oct 22, 2026Oct 23, 2026Not stated
Sales Operations AnalystBracknell, United KingdomOct 22, 2026Oct 23, 2026Not stated
Lab Technician III - Front End Day ShiftAthenry, IrelandOct 22, 2026Oct 23, 2026Not stated
Business Intelligence Analyst - Healthcare (m/w/d)Mainz, GermanyOct 22, 2026Oct 23, 2026Not stated
Team Lead Rechnungsstellung - Healthcare (m/w/d) - 1-jähriger befristeter VertragMainz, GermanyOct 22, 2026Oct 23, 2026Not stated
Senior Business Analyst and Business Relationship Manager (E-commerce)BracknellOct 21, 2026Oct 12, 2026Senior
Inside Sales Representative – HCP Acquisition & Account GrowthVancouver, British ColumbiaOct 21, 2026Oct 12, 2026Entry
Inside Sales Representative – Patient Acquisition & Account GrowthRemote British ColumbiaOct 21, 2026Oct 12, 2026Mid
Contract Administration RepresentativeVilnius, LithuaniaOct 21, 2026Oct 12, 2026Mid
Automation Technician (Weekend Day Shift)Athenry, IrelandOct 21, 2026Oct 12, 2026Mid
Staff IT Business Systems Analyst- Strategic InitiativesRemote - United StatesOct 21, 2026Oct 16, 2026Not stated
Engineering Technician 3Penang, MalaysiaOct 21, 2026Oct 21, 2026Not stated
Sr TrainerTaguig, PhilippinesOct 21, 2026Oct 21, 2026Not stated
Sr TrainerCebu, PhilippinesOct 21, 2026Oct 21, 2026Not stated
Sr Business Process Analyst2 locations (listed on the posting)Oct 21, 2026Oct 21, 2026Not stated
District Business Manager - Northern Illinois & WisconsinChicago, IllinoisOct 21, 2026Oct 21, 2026Not stated
Manufacturing Technician 2 ( Monday - Friday 6:00AM - 2:30 PM )San Diego, CaliforniaOct 21, 2026Oct 22, 2026Not stated
Staff Algorithm Engineer - Advanced Sensing AlgorithmsRemote CaliforniaOct 21, 2026Oct 22, 2026Not stated
Senior Algorithm Engineer - Sensing AlgorithmsRemote CaliforniaOct 21, 2026Oct 22, 2026Not stated
Sr ParalegalSan Diego, CaliforniaOct 21, 2026Oct 22, 2026Not stated
Lead Legal CounselSan Diego, CaliforniaOct 21, 2026Oct 22, 2026Not stated
Sr Manager - Application AutomationSan Diego, CaliforniaOct 21, 2026Oct 22, 2026Not stated
Territory Business Manager - Montreal East - AbitibiRemote QuebecOct 21, 2026Oct 22, 2026Not stated
IT Infrastructure Asset & Lifecycle Analyst2 locations (listed on the posting)Oct 20, 2026Oct 12, 2026Senior
Enterprise Applications - Integration Support2 locations (listed on the posting)Oct 20, 2026Oct 12, 2026Mid
Senior Commercial Forecasting Analyst – Barcelona, Spain3 locations (listed on the posting)Oct 20, 2026Oct 12, 2026Senior
Customer Advocacy GeneralistVilnius, LithuaniaOct 20, 2026Oct 20, 2026Not stated
Medical Affairs Specialist (Maternity Cover)Vilnius, LithuaniaOct 20, 2026Oct 20, 2026Not stated
Staff Enterprise Capital Management AnalystSan Diego, CaliforniaOct 20, 2026Oct 21, 2026Not stated
Process Development Engineer 2San Diego, CaliforniaOct 20, 2026Oct 21, 2026Not stated
Customer Account Support AnalystSan Diego, CaliforniaOct 20, 2026Oct 21, 2026Not stated
Document Control Specialist 3 - Evening ShiftAthenry, IrelandOct 20, 2026Oct 21, 2026Not stated
Executive Assistant, Chief People & Culture OfficerSan Diego, CaliforniaOct 20, 2026Oct 21, 2026Not stated
Production Operator - DaysAthenry, IrelandOct 20, 2026Oct 21, 2026Not stated
QA Engineer 2Penang, MalaysiaOct 20, 2026Oct 21, 2026Not stated
Manager Quality AssuranceTokyo, JapanOct 19, 2026Oct 19, 2026Not stated
District Business Manager (Tampa, FL)Tampa, FloridaOct 19, 2026Oct 20, 2026Not stated
District Business Manager (Nashville, TN)Nashville, TennesseeOct 19, 2026Oct 20, 2026Not stated
District Business Manager - Houston, TXHouston, TexasOct 19, 2026Oct 20, 2026Not stated
District Business Manager - New Shore, NJRemote New JerseyOct 19, 2026Oct 20, 2026Not stated

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

All 305 jobs →

Connect

See your connections at Dexcom on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12

Feedback